Ranbaxy Laboratories Limited

218 articles about Ranbaxy Laboratories Limited

• Ranbaxy Laboratories Gets FDA OK for Acne Treatment Absorica

  5/29/2012

• Ranbaxy Laboratories Plans to Relaunch Skin Drug in the US

  5/21/2012

• Lipitor Clone Lifts Ranbaxy Laboratories While Pfizer Inc. Bids Drug Goodbye

  5/11/2012

• Ranbaxy Laboratories Q1 Jumps 300%, What are Analysts Saying?

  5/10/2012

• Ranbaxy Laboratories Creates India's First New Drug

  4/30/2012

• Ranbaxy Laboratories Launches Generic Atorvastatin in European Markets

  3/6/2012

• Pfizer Inc., Ranbaxy Laboratories Sued Over Alleged Anti-Competitive Scheme

  2/7/2012

• Ranbaxy Laboratories May Face Permanent Injunction in U.S

  1/26/2012

• Daiichi Sankyo, Inc. Officials to Monitor New Ranbaxy Laboratories Unit

  1/18/2012

• Ranbaxy Laboratories Sets Aside $500 Million to Settle US Probe, Signs Consent Decree With FDA

  12/21/2011

• Ranbaxy Laboratories Global Consumer Healthcare & Aanjaneya Lifecare Declared Winners in "Neutraceutical Segments" & "Company of the Year Award" Respectively at 4th Annual Pharmaceutical Leadership Awards 2011

  12/19/2011

• Ranbaxy Laboratories Release: FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor

  12/1/2011

• Ranbaxy Laboratories Gets Approval for First Drug from an Indian Pharma

  11/3/2011

• Ranbaxy Laboratories Recalls Three Drugs From UK Market

  10/17/2011

• Ranbaxy Laboratories Climbs on Lipitor Launch Buzz

  9/8/2011

• Pfizer Inc.'s Generic Lipitor May be Delayed by Ranbaxy Laboratories Problems

  9/1/2011

• Lipitor Generic Rights May be Sold Should Ranbaxy Laboratories's Approval Come Too Late

  8/18/2011

• Ranbaxy Laboratories Closes Plant in the US

  8/10/2011

• Ranbaxy Laboratories Launches Letrozole Tablets on Day-1 in UK, Romania, France

  7/25/2011

• Biotech Innovator Divine Skin Partners with Giant Ranbaxy Laboratories to Sell Hair-Growth Treatments

  7/18/2011